检索结果 - Quan Sing Ng

  • Showing 1 - 10 results of 10
Refine Results
  1. 1
    EGFR Mutation Subtypes Influence Survival Outcomes following First-Line Gefitinib Therapy in Advanced Asian NSCLC Patients

    EGFR Mutation Subtypes Influence Survival Outcomes following First-Line Gefitinib Therapy in Advanced Asian NSCLC Patients 由 Natalia Sutiman, Shao Weng Tan, Eng Huat Tan, Wan‐Teck Lim, Ravindran Kanesvaran, Quan Sing Ng, Amit Jain, Mei‐Kim Ang, Wan Ling Tan, Chee‐Keong Toh, Balram Chowbay

    出版 2016
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  2. 2
    A Phase II Study of Pazopanib in Asian Patients with Recurrent/Metastatic Nasopharyngeal Carcinoma

    A Phase II Study of Pazopanib in Asian Patients with Recurrent/Metastatic Nasopharyngeal Carcinoma 由 Wan‐Teck Lim, Quan‐Sing Ng, Percy Ivy, Swan-Swan Leong, Onkar Singh, Balram Chowbay, Fei Gao, Choon Hua Thng, Boon-Cher Goh, Daniel Shao-Weng Tan, Tong San Koh, Chee‐Keong Toh, Eng-Huat Tan

    出版 2011
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  3. 3
    Intertumor heterogeneity of non‐small‐cell lung carcinomas revealed by multiplexed mutation profiling and integrative genomics

    Intertumor heterogeneity of non‐small‐cell lung carcinomas revealed by multiplexed mutation profiling and integrative genomics 由 Daniel S.W. Tan, Sophie Camilleri‐Bröet, Eng Huat Tan, Marco Alifano, Wan‐Teck Lim, Antonio Bobbio, Shenli Zhang, Quan‐Sing Ng, Mei‐Kim Ang, N. Gopalakrishna Iyer, Angela Takano, Kiat Hon Lim, Jean‐François Régnard, Patrick Tan, Philippe Broët

    出版 2014
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  4. 4
    ERA 223: A phase III trial of radium-223 (Ra-223) in combination with abiraterone acetate and prednisone/prednisolone for the treatment of asymptomatic or mildly symptomatic chemotherapy-naïve patients (pts) with bone-predominant metastatic castration-resistant prostate cancer (mCRPC)

    ERA 223: A phase III trial of radium-223 (Ra-223) in combination with abiraterone acetate and prednisone/prednisolone for the treatment of asymptomatic or mildly symptomatic chemot... 由 Mitchell R. Smith, Chris Parker, Fred Saad, K. Miller, Bertrand Tombal, Quan Sing Ng, Martin Bögemann, В. Б. Матвеев, Josep M. Piulats, Luis Eduardo Rosa Zucca, Axel Heidenreich, Yoshiyuki Kakehi, A. Zhang, Heiko Krissel, Jiayu Shen, V. Wagner, Celestia S. Higano

    出版 2018
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  5. 5
    A phase Ib study of selumetinib (AZD6244, ARRY-142886) in combination with sorafenib in advanced hepatocellular carcinoma (HCC)

    A phase Ib study of selumetinib (AZD6244, ARRY-142886) in combination with sorafenib in advanced hepatocellular carcinoma (HCC) 由 Wai Meng David Tai, Wei Peng Yong, Cindy Lim, Lauren Low, Chee Kian Tham, Tong San Koh, Quan Sing Ng, W.W. Wang, L.Z. Wang, Septian Hartano, Choon Hua Thng, Hung Huynh, Kok-Hing Lim, Han Chong Toh, Boon Cher Goh, Su Pin Choo

    出版 2016
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  6. 6
    Pan-Asian adaptation of the EHNS–ESMO–ESTRO Clinical Practice Guidelines for the diagnosis, treatment and follow-up of patients with squamous cell carcinoma of the head and neck

    Pan-Asian adaptation of the EHNS–ESMO–ESTRO Clinical Practice Guidelines for the diagnosis, treatment and follow-up of patients with squamous cell carcinoma of the head and neck... 由 Bhumsuk Keam, Jean-Pascal Machiels, Hye Ryun Kim, Lisa Licitra, Wojciech Golusiński, Vincent Grégoire, Y.G. Lee, Claus Belka, Ye Guo, Senthil Rajappa, Makoto Tahara, M. Azrif, Mei‐Kim Ang, Muh‐Hwa Yang, C.-H. Wang, Quan Sing Ng, W.I. Wan Zamaniah, Naomi Kiyota, S. Babu, Kaili Yang, Giuseppe Curigliano, Solange Peters, T.W. Kim, Takayuki Yoshino, George Pentheroudakis

    出版 2021
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  7. 7
    Clinical efficacy and biomarker analysis of dual PD-1/CTLA-4 blockade in recurrent/metastatic EBV-associated nasopharyngeal carcinoma

    Clinical efficacy and biomarker analysis of dual PD-1/CTLA-4 blockade in recurrent/metastatic EBV-associated nasopharyngeal carcinoma 由 Wan‐Teck Lim, Hsiang‐Fong Kao, Lisda Suteja, Constance H. Li, Hong Sheng Quah, Daniel S.W. Tan, Sze Huey Tan, Eng-Huat Tan, Wan-Ling Tan, Justina Nadia Lee, Felicia Yu-Ting Wee, Amit Jain, Boon Cher Goh, Melvin L.K. Chua, Bin-Chi Liao, Quan Sing Ng, Ruey‐Long Hong, Mei‐Kim Ang, Joe Yeong, N. Gopalakrishna Iyer

    出版 2023
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  8. 8
    Detection of circulating tumor DNA with ultradeep sequencing of plasma cell‐free DNA for monitoring minimal residual disease and early detection of recurrence in early‐stage lung cancer

    Detection of circulating tumor DNA with ultradeep sequencing of plasma cell‐free DNA for monitoring minimal residual disease and early detection of recurrence in early‐stage lung c... 由 Aaron C. Tan, Gillianne Lai, Stephanie P.L. Saw, Kevin Lee Min Chua, Angela Takano, Boon‐Hean Ong, Tina Koh, Amit Jain, Wan Ling Tan, Quan Sing Ng, Ravindran Kanesvaran, Tanujaa Rajasekaran, Ekaterina Kalashnikova, Derrick Renner, Sumedha Sudhaman, Meenakshi Malhotra, Himanshu Sethi, Minetta C. Liu, Alexey Aleshin, Wan‐Teck Lim, Eng‐Huat Tan, Anders J. Skanderup, Mei‐Kim Ang, Daniel S.W. Tan

    出版 2024
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  9. 9
    Association of Clinicopathologic and Molecular Tumor Features With Recurrence in Resected Early-Stage Epidermal Growth Factor Receptor–Positive Non–Small Cell Lung Cancer

    Association of Clinicopathologic and Molecular Tumor Features With Recurrence in Resected Early-Stage Epidermal Growth Factor Receptor–Positive Non–Small Cell Lung Cancer 由 Stephanie P.L. Saw, Siqin Zhou, Jianbin Chen, Gillianne Lai, Mei‐Kim Ang, Kevin Lee Min Chua, Ravindran Kanesvaran, Quan Sing Ng, Amit Jain, Wan Ling Tan, Tanujaa Rajasekaran, Wan‐Teck Lim, Aaron C. Tan, Kam Weng Fong, Angela Takano, Xin Cheng, Kiat Hon Lim, Tina Koh, Boon‐Hean Ong, Eng Huat Tan, Chee‐Keong Toh, Anders J. Skanderup, Sze Huey Tan, Daniel Shao-Weng Tan

    出版 2021
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  10. 10
    Pembrolizumab monotherapy versus chemotherapy in platinum-pretreated, recurrent or metastatic nasopharyngeal cancer (KEYNOTE-122): an open-label, randomized, phase III trial

    Pembrolizumab monotherapy versus chemotherapy in platinum-pretreated, recurrent or metastatic nasopharyngeal cancer (KEYNOTE-122): an open-label, randomized, phase III trial 由 Anthony T.�C. Chan, V.H.F. Lee, R-L. Hong, M-J. Ahn, Wan Qin Chong, S. B. Kim, Gwo Fuang Ho, Priscilla B. Caguioa, Nuttapong Ngamphaiboon, Cheryl Ho, Mubashir Aziz, Quan Sing Ng, C-J. Yen, Nopadol Soparattanapaisarn, Roger KC Ngan, S.K. Kho, M.L.A. Tiambeng, Tak Yun, Virote Sriuranpong, Alain P. Algazi, Andy S. K. Cheng, Erminia Massarelli, Ramona F. Swaby, Sanatan Saraf, Jianda Yuan, Lillian L. Siu

    出版 2022
    获取全文
    Artigo
    加到收藏夹
    Saved in:

检索工具: